Mirae Asset Global Investments’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.8K	Buy	4,834 +492	+11%	+$2.13K	﹤0.01%	1462
2025 Q4	$15.5K	Buy	4,342 +1,021	+31%	+$6.25K	﹤0.01%	1566
2025 Q3	$29.6K	Buy	3,321 +23	+0.7%	+$233	﹤0.01%	1438
2025 Q2	$30.4K	Buy	3,298 +452	+16%	+$3.86K	﹤0.01%	1330
2025 Q1	$24.8K	Buy	2,846 +20	+0.7%	+$189	﹤0.01%	1364
2024 Q4	$34.2K	Sell	2,826 -241	-8%	-$1.85K	﹤0.01%	1331
2024 Q3	$17.4K	Buy	3,067 +540	+21%	+$3.12K	﹤0.01%	1451
2024 Q2	$10.8K	Sell	2,527 -52,323	-95%	-$212K	﹤0.01%	1456
2024 Q1	$383K	Buy	54,850 +12,728	+30%	+$71.6K	﹤0.01%	2010
2023 Q4	$392K	Sell	42,122 -683	-2%	-$4.7K	﹤0.01%	2086
2023 Q3	$280K	Sell	42,805 -3,187	-7%	-$25.4K	﹤0.01%	2156
2023 Q2	$371K	Sell	45,992 -5,732	-11%	-$49.1K	﹤0.01%	2082
2023 Q1	$443K	Buy	51,724 +17,579	+51%	+$175K	﹤0.01%	1985
2022 Q4	$316K	Buy	34,145 +4,507	+15%	+$48.1K	﹤0.01%	2133
2022 Q3	$306K	Buy	29,638 +8,641	+41%	+$91.2K	﹤0.01%	2148
2022 Q2	$210K	Buy	+20,997	New	+$199K	﹤0.01%	2134